학술논문
Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study
Document Type
Article
Author
Nukaya, T.; Takahara, K.; Yoshizawa, A.; Saruta, M.; Shiroki, R.; Yano, Y.; Ohno, T.; Uchimoto, T.; Yamazaki, S.; Tokushige, S.; Nishimura, K.; Tsujino, T.; Nakamori, K.; Komura, K.; Inamoto, T.; Azuma, H.; Fukuokaya, W.; Yamamoto, S.; Iwatani, K.; Urabe, F.; Mori, K.; Yanagisawa, T.; Tsuduki, S.; Miki, J.; Kimura, T.; Adachi, T.; Hirasawa, Y.; Hashimoto, T.; Ohno, Y.
Source
In: Clinical Genitourinary Cancer . (Clinical Genitourinary Cancer, February 2024, 22(1):76-83)
Subject
Language
English
ISSN
19380682
15587673
15587673